Andrea James
Director of Finance/CFO at INSIGHT MOLECULAR DIAGNOSTICS INC.
Net worth: 1 M $ as of 29/11/2025
Profile
Ms. Andrea James is a Chief Financial Officer at Insight Molecular Diagnostics, Inc. Ms. James was previously employed as a Chief Communications Officer by Axon Enterprise, Inc. and a Vice President by Colliers Securities LLC.
She received her undergraduate degree from American University and a graduate degree from Northwestern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/10/2025 | 189,056 ( 0.66% ) | 1 M $ | 29/11/2025 |
Latest news about Andrea James
Andrea James active positions
| Companies | Position | Start |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Director of Finance/CFO | 16/06/2024 |
Former positions of Andrea James
| Companies | Position | End |
|---|---|---|
| AXON ENTERPRISE, INC. | Investor Relations Contact | 26/09/2022 |
Colliers Securities LLC
Colliers Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Training of Andrea James
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Axon Enterprise, Inc.
Axon Enterprise, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures advanced conducted electrical weapons and software | Electronic Technology |
Colliers Securities LLC
Colliers Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
OncoCyte Corp. Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer |
- Stock Market
- Insiders
- Andrea James
















